Pharmaceutical industry – Page 56
-
Business
First HIV drug approved as prevention
Truvada tablets can reduce the risk of infection for an HIV-negative person
-
Business
Drug spending to hit $1.2tn in 2016
Growth is expected to bottom out at 3–4% for 2012 and then rise to 5–7% for 2016
-
Business
GSK drug shines in HIV trial
HIV–Aids drug candidate dolutegravir outperformed Atripla tablets in Phase III
-
News
China targets patented drugs with law change
Domestic drug companies can apply for licences to produce patented drugs when public health overrides intellectual property considerations
-
BusinessInterview: EMA head Guido Rasi
Guido Rasi, head of the European Medicines Agency, wants to see greater transparency in drug development
-
Business
Is Sanofi cutting jobs in France?
News outlets are reporting plans to cut 1000-2000 employees in France
-
Business
BMS and AstraZeneca buy Amylin for $7bn
Two pharma giants have teamed up to buy US biotech Amylin, responsible for the Byetta and Bydureon anti-diabetes brands
-
Business$3bn GSK fine sets new industry record
The fine relates to off label marketing and is the largest payment of its kind ever made by a drug company
-
News
FDA green lights new obesity drug
Agency approval for prescription only obesity drug is first for 13 years
-
Business
Roche rapped for side-effect reporting failure
European medicines regulator names and shames Swiss giant for not disclosing 80,000 instances of potential adverse drug reactions
-
Business
Roche cuts 1000 jobs with US R&D site closure
Streamlining strategy will see oncology and virology research moved to Switzerland and Germany
-
Business
Nasonex patent ruling goes against Merck & Co
The court ruled that the Merck patent was valid - but Apotex won’t infringe it with its product
-
Business
Lundbeck to lose 600 jobs
Danish drug maker Lundbeck has said it will cut 600 jobs as it reorganises its European operations
-
Business
Good signs for Merck & Co insomnia pill
Suvorexant switches off wakefulness to help patients drop off quicker and stay asleep longer
-
Business
More testing needed for ridaforolimus
Marketing approval for anti-cancer drug ridaforolimus has been held up in the US
-
Business
Three pronged approach puts brakes on US breast cancer
US approval for anti-HER2 therapy Perjeta (pertuzumab) against breast cancer
-
Business
Pfizer to spin off animal health business
New company Zoetis should start independent trading by July 2013
-
-
News€224 million EU antibiotics initiative launched
The project will bring together the pharmaceutical industry and academia, but some institutes have reservations
-
Business
Takeda buys into Brazil for 540m reals
Multilab makes generics and over-the-counter branded products